The Septic Shock Market Research Report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted Septic Shock market Size from 2017 to 2030 segmented by seven major markets.
The report provides a detailed current Septic Shock treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Septic Shock: An Overview
According to the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3), septic shock is defined by persisting hypotension that requires vasopressors to maintain a mean arterial pressure of 65 mmHg or higher and a serum lactate level greater than 2 mmol/L (18 mg/dL) despite adequate volume resuscitation. The average mortality of septic shock is 40%.
The risk of septic shock is higher in newborns and infants, elderly people, pregnant women, and individuals with chronic diseases. Once the patient is diagnosed with sepsis, he/she is admitted to the intensive care unit (ICU) to support the body’s functions and organs. The treatment may include intravenous antibiotics, vasopressors, insulin, and corticosteroids.
Septic Shock Market Key Facts
-
A study conducted by Hari et al., titled “Epidemiology of sepsis and septic shock in critical care units: comparison between sepsis-2 and sepsis-3 populations using a national critical care database” shows that the sepsis-2 septic shock and sepsis-3 septic shock accounted for 23.4% and 6.0%, respectively, of admissions to adult general ICUs in England over the 5 year period.
-
As per the study conducted by Vincent et al., titled “Frequency and mortality of septic shock in Europe and North America: a systematic review and meta-analysis,” the frequency of septic shock were estimated at 10.4% in studies reporting values for patients diagnosed at ICU admission and at 8.3% in studies reporting values for patients diagnosed at any time during the ICU stay.
Key Benefits of Septic Shock Market Report
-
The market report provides an in-depth analysis of Septic Shock Market Size, Share, Trend, and Epidemiology Forecast till 2030 in the seven major markets (i.e. the United States, EU5 (Germany, Italy, Spain, France, and the UK) and Japan.
-
The report will help in developing business strategies by understanding the Septic Shock Market Trends, recent developments, key players, and future market competition that will shape and drive the market growth in the upcoming years.
-
The market report covers the Septic Shock current treatment practices, emerging drugs, market share of the individual therapies in the seven major markets.
-
The report provides a detailed assessment of the Septic Shock market in terms of market drivers & barriers, unmet needs, market opportunities, patient population, detailed comparative analysis of pipeline products including clinical and non-clinical stage products, and other factors.
The Septic Shock market is expected to rise in the coming years owing to the increasing incidence and the expected launch of emerging therapies.
The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Septic Shock market size and share by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology.
The report gives a thorough detail of the Septic Shock market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
Request for Sample @ Septic Shock Therapeutics Market Assessment
Septic Shock Epidemiology
The epidemiology section covers insights about the historical and current Septic Shock patient pool and forecasted trends for every seven major countries from 2017 to 2030. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Septic Shock Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Septic Shock market or expected to get launched in the market during the study period. The analysis covers Septic Shock market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
The report also covers the Septic Shock Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.
Some of the key companies in the Septic Shock Market include:
-
Adrenomed AG
-
Vivacelle Bio
-
Inotrem
-
Atox Bio
-
AM-Pharma
And others.
Septic Shock therapies covered in the report include
-
Adrecizumab
-
VBI-S
-
Nangibotide
-
Reltecimod (AB103)
And many others.
Table of Content
1. Key Insights
2. Executive Summary
3. Septic Shock Competitive Intelligence Analysis
4. Septic Shock Market Overview at a Glance
5. Septic Shock Disease Background and Overview
6. Septic Shock Patient Journey
7. Septic Shock Epidemiology and Patient Population
8. Septic Shock Treatment Algorithm, Current Treatment, and Medical Practices
9. Septic Shock Unmet Needs
10. Key Endpoints of Septic Shock Treatment
11. Septic Shock Marketed Products
12. Septic Shock Emerging Therapies
13. Septic Shock Seven Major Market Analysis
14. Attribute Analysis
15. Septic Shock Market Outlook (7 major markets)
16. Septic Shock Access and Reimbursement Overview
17. KOL Views on the Septic Shock Market.
18. Septic Shock Market Drivers
19. Septic Shock Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.
Get FREE sample copy at: https://www.delveinsight.com/sample-request/septic-shock-market
Latest Reports By DelveInsight
Septic Shock Pipeline Insights
Septic Shock Pipeline Insight, 2021 report by DelveInsight outlines comprehensive insights of present clinical development scenario and growth prospects across the Septic Shock market.
Muscle Atrophy/ Wasting Syndrome Market
DelveInsight’s “Muscle Atrophy/ Wasting Syndrome Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Muscle Atrophy/ Wasting Syndrome market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/